# Dalian Wanchun Bulin Pharmaceutical Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/dalian-wanchun-bulin-pharmaceutical-co

- Industry: Biotechnology
- Headquarters: Dalian, China
- Latest round: Series A (Nov 26, 2019)
- Investors on record: 2

## About

Established in 2015 and based in Dalian, China, Dalian Wanchun Bulin Pharmaceutical Co.,Ltd operates as a clinical stage biopharmaceutical company that focuses on immune tumor anti-cancer.

The company provides immuno-oncology and anti-cancer drugs for cancer treatment field. The product of the company includes first in class of anti-cancer drugs, such as punabulin.

## Funding rounds

- Series A, Nov 26, 2019 — Efung Capital, Teewin

## Investors

- Efung Capital (https://capitalatlas.ai/funds/efung-capital) — Series A
- Teewin — Series A